Menu
GeneBe

3-38606007-C-T

Variant summary

Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP2PP3

The NM_001099404.2(SCN5A):c.1282G>A(p.Glu428Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000471 in 1,613,554 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000047 ( 0 hom. )

Consequence

SCN5A
NM_001099404.2 missense

Scores

5
5
8

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts P:1U:9O:1

Conservation

PhyloP100: 1.95
Variant links:
Genes affected
SCN5A (HGNC:10593): (sodium voltage-gated channel alpha subunit 5) The protein encoded by this gene is an integral membrane protein and tetrodotoxin-resistant voltage-gated sodium channel subunit. This protein is found primarily in cardiac muscle and is responsible for the initial upstroke of the action potential in an electrocardiogram. Defects in this gene have been associated with long QT syndrome type 3 (LQT3), atrial fibrillation, cardiomyopathy, and Brugada syndrome 1, all autosomal dominant cardiac diseases. Alternative splicing results in several transcript variants encoding different isoforms. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 6 ACMG points.

PM1
In a helix (size 27) in uniprot entity SCN5A_HUMAN there are 10 pathogenic changes around while only 2 benign (83%) in NM_001099404.2
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant where missense usually causes diseases, SCN5A
PP3
MetaRNN computational evidence supports a deleterious effect, 0.795

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SCN5ANM_001099404.2 linkuse as main transcriptc.1282G>A p.Glu428Lys missense_variant 10/28 ENST00000413689.6
SCN5ANM_000335.5 linkuse as main transcriptc.1282G>A p.Glu428Lys missense_variant 10/28 ENST00000423572.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SCN5AENST00000413689.6 linkuse as main transcriptc.1282G>A p.Glu428Lys missense_variant 10/285 NM_001099404.2 P4
SCN5AENST00000423572.7 linkuse as main transcriptc.1282G>A p.Glu428Lys missense_variant 10/281 NM_000335.5 A1Q14524-2

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152162
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000482
AC:
12
AN:
248958
Hom.:
0
AF XY:
0.0000444
AC XY:
6
AN XY:
135024
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000111
Gnomad SAS exome
AF:
0.0000655
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000709
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000465
AC:
68
AN:
1461392
Hom.:
0
Cov.:
31
AF XY:
0.0000426
AC XY:
31
AN XY:
726936
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000151
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000486
Gnomad4 OTH exome
AF:
0.0000497
GnomAD4 genome
AF:
0.0000526
AC:
8
AN:
152162
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74334
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000882
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000947
Hom.:
0
Bravo
AF:
0.0000567
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000239
AC:
2
ExAC
AF:
0.0000496
AC:
6
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000178

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:3
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicJan 08, 2021- -
Uncertain significance, criteria provided, single submitterclinical testingInvitaeJan 13, 2024This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 428 of the SCN5A protein (p.Glu428Lys). This variant is present in population databases (rs199473111, gnomAD 0.01%). This missense change has been observed in individuals with atrial fibrillation, Brugada syndrome, and/or long QT syndrome (PMID: 15996170, 18378609, 19026623, 24784157, 28341781, 29449639, 30193851, 33919104, 34019817). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 30048). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies have shown that this missense change affects SCN5A function (PMID: 29449639, 34019817). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxApr 21, 2022Reported in association with atrial fibrillation, Brugada syndrome, LQTS, and sudden unexplained death (Darbar et al., 2008; Millat et al., 2009; Yamagata et al., 2017; Berthome et al., 2019; Hong et al., 2021; Iglesias et al., 2021; Ripoll-Vera et al., 2021); Reported in a family with LQTS in which the proband harbored three clinically relevant variants, however, the SCN5A variant did not independently segregate with disease in family members (Wu et al., 2018); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Functional studies have demonstrated conflicting evidence regarding impact on electrophysiological properties and protein function (Wu et al., 2018; Hong et al., 2021; Ishikawa et al., 2021); LQTS is caused by gain of function variants in the SCN5A channel (NaV1.5), while Brugada syndrome is caused by loss of function variants; as this variant has been identified in individuals with diseases that have different mechanisms of pathogenicity, its clinical significance is uncertain; This variant is associated with the following publications: (PMID: 22581653, 19026623, 24055113, 24784157, 25637381, 21596231, 15996170, 28341781, 29449639, 34219138, 34019817, 30193851, 18378609, 33919104, 32917565, 34831398) -
Cardiac arrhythmia Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthDec 01, 2023This missense variant replaces glutamic acid with lysine at codon 428 of the SCN5A protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). Functional studies have shown that this variant causes increased peak sodium current but has no effect on late channel current in vitro (PMID: 29449639, 34019817). This variant has also been shown to cause abnormal electrophysiological profiles in cardiomyocytes derived from induced pluripotent stem cells from Glu428Lys carriers who were affected with atrial fibrillation (PMID: 34019817). This variant has been reported in two individuals affected with long QT syndrome (PMID: 19026623, 29449639), one individual affected with Brugada syndrome (PMID: 28341781), two individuals affected with sudden cardiac death (PMID: 32917565, 33919104, 37432518), as well as in three related individuals who were asymptomatic with no QT prolongation (PMID: 29449639). One of these affected individuals also carried two pathogenic variants in other genes that could explain the observed phenotype (PMID: 29449639). This variant has been shown to segregate with atrial fibrillation in three individuals from a family (PMID 18378609, 34019817). This variant has been identified in 14/280354 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Uncertain significance, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthJan 03, 2024This missense variant replaces glutamic acid with lysine at codon 428 of the SCN5A protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). Functional studies have shown that this variant causes increased peak sodium current but has no effect on late channel current in vitro (PMID: 29449639, 34019817). This variant has also been shown to cause abnormal electrophysiological profiles in cardiomyocytes derived from induced pluripotent stem cells from Glu428Lys carriers who were affected with atrial fibrillation (PMID: 34019817). This variant has been reported in two individuals affected with long QT syndrome (PMID: 19026623, 29449639), one individual affected with Brugada syndrome (PMID: 28341781), two individuals affected with sudden cardiac death (PMID: 32917565, 33919104, 37432518), as well as in three related individuals who were asymptomatic with no QT prolongation (PMID: 29449639). One of these affected individuals also carried two pathogenic variants in other genes that could explain the observed phenotype (PMID: 29449639). This variant has been shown to segregate with atrial fibrillation in three individuals from a family (PMID 18378609, 34019817). This variant has been identified in 14/280354 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Atrial fibrillation Uncertain:1Other:1
not provided, no classification providedliterature onlyCardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust-This variant has been reported as associated with Atrial fibrillation in the following publications (PMID:18378609). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Uncertain significance, no assertion criteria providedresearchCSER _CC_NCGL, University of WashingtonJun 01, 2014- -
Atrial fibrillation, familial, 10 Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMApr 15, 2008- -
SCN5A-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesFeb 27, 2024The SCN5A c.1282G>A variant is predicted to result in the amino acid substitution p.Glu428Lys. This variant has been reported in individuals with atrial fibrillation, Brugada syndrome, sudden cardiac death, or long QT syndrome (Table 2, Darbar et al. 2008. PubMed ID: 18378609; Yamagata et al. 2017. PubMed ID: 28341781; Iglesias et al. 2021. PubMed ID: 33919104; Hata et al. 2023. PubMedID: 37432518; Wu et al. 2018. PubMed ID: 29449639). However, variants in additional genes were also reported in some of these patients (Iglesias et al. 2021. PubMed ID: 33919104; Hata et al. 2023. PubMedID: 37432518). This variant was also reported in a family with long QT syndrome and syncope along with two variants in relevant genes; however the p.Glu428Lys variant did not segregate with disease (Wu et al. 2018. PubMed ID: 29449639). This variant is reported in 0.010% of alleles in individuals of East Asian descent in gnomAD. The results of in vitro experimental studies of this variant are inconclusive (Table S4, Ishikawa et al. 2021. PubMed ID: 34219138; Figure 4, Hong et al. 2021. PubMed ID: 34019817). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
SUDDEN INFANT DEATH SYNDROME;C1832680:Dilated cardiomyopathy 1E;C1837845:Sick sinus syndrome 1;C1859062:Long QT syndrome 3;C1879286:Progressive familial heart block, type 1A;C2751898:Ventricular fibrillation, paroxysmal familial, type 1;C3151464:Atrial fibrillation, familial, 10;C4551804:Brugada syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsMar 28, 2022- -
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 31, 2023The p.E428K variant (also known as c.1282G>A), located in coding exon 9 of the SCN5A gene, results from a G to A substitution at nucleotide position 1282. The glutamic acid at codon 428 is replaced by lysine, an amino acid with similar properties. This variant has been detected in three individuals in a family with atrial fibrillation (Darbar D et al. Circulation. 2008;117:1927-35). This variant has also been detected in long QT syndrome (LQTS) and Brugada syndrome cohorts; however, clinical details were limited (Millat G et al. Clin Biochem. 2009;42(6):491-9; Yamagata K et al. Circulation. 2017;135:2255-2270). In one family with LQTS, this variant co-occurred with alterations in KCNH2 and KCNQ1. The p.E428K variant and the KCNQ1 variant were inherited from the proband's maternal side which had no history of LQTS. The same study reported in vitro assay results that suggested this variant may have some impact on channel function (Wu J et al. Sci Rep. 2018;8(1):3129). This variant has also been detected in multipe individuals from exome sequencing cohorts and arrhythmia control cohorts (Maekawa K et al. Ann Hum Genet. 2005;69(Pt 4):413-28; Lawrence L et al. Genet. Med. 2014;16:741-50; Weeke P et al. Circ Cardiovasc Genet. 2015;8(1):58-63; Amendola LM et al. Genome Res. 2015;25:305-15; Kapplinger JD et al. Circ Cardiovasc Genet. 2015;8:582-95). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
CardioboostArm
Benign
0.00031
CardioboostCm
Benign
0.076
BayesDel_addAF
Uncertain
0.11
D
BayesDel_noAF
Pathogenic
0.14
Cadd
Uncertain
24
Dann
Uncertain
1.0
Eigen
Benign
-0.041
Eigen_PC
Benign
0.078
FATHMM_MKL
Uncertain
0.83
D
M_CAP
Pathogenic
0.45
D
MetaRNN
Pathogenic
0.79
D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
0.90
D
MutationTaster
Benign
0.97
D;D;D;D;D;D;D;D;D;D
PrimateAI
Uncertain
0.64
T
PROVEAN
Uncertain
-3.1
D;D;D;D;D;D;D;D;D
REVEL
Pathogenic
0.66
Sift
Benign
0.085
T;T;T;T;T;T;T;T;T
Sift4G
Benign
0.37
T;T;T;T;T;T;T;T;T
Polyphen
0.041
B;D;.;B;.;B;P;.;.
Vest4
0.85
MVP
0.91
MPC
0.78
ClinPred
0.22
T
GERP RS
4.7
Varity_R
0.13
gMVP
0.83

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199473111; hg19: chr3-38647498; COSMIC: COSV61141514; API